Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arvaya HealthcareBOM:524723 51 ROC (Joel Greenblatt) % is 10.84% as of Jun. 2026. GuruFocus rates BOM:524723 with a GF Score™ of 51/100 and a GF Value™ of ₹200.72 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 119 Medical Distribution companies, Arvaya Healthcare ranks worse than 61.34% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Arvaya Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Jun. 2026 was 10.84%.
The historical rank and industry rank for Arvaya Healthcare's ROC (Joel Greenblatt) % or its related term are showing as below:
BOM:524723'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -36.11 Med: -6.24 Max: 36.3
Current: 9.6
During the past 13 years, Arvaya Healthcare's highest ROC (Joel Greenblatt) % was 36.30%. The lowest was -36.11%. And the median was -6.24%.
BOM:524723's ROC (Joel Greenblatt) % is ranked worse than 61.34% of 119
companies
in the Medical Distribution industry
Industry Median: 16.13
vs BOM:524723: 9.60
Arvaya Healthcare's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 0.00% per year.
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Arvaya Healthcare ROC (Joel Greenblatt) % Related Terms
Arvaya Healthcare ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Arvaya Healthcare's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:524723 vs MCK, COR, CAH: ROC (Joel Greenblatt) % Comparison
For the Medical Distribution subindustry, Arvaya Healthcare's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arvaya Healthcare ROC (Joel Greenblatt) % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arvaya Healthcare's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Arvaya Healthcare's ROC (Joel Greenblatt) % falls into.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Jun. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 10.84% mean?
Arvaya Healthcare (BOM:524723) has a ROC (Joel Greenblatt) % of 10.84% as of Jun. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Arvaya Healthcare and its competitors. According to the industry distribution chart, Arvaya Healthcare ranks #73 out of 119 companies in the Medical Distribution industry, placing it in the top 61.3%.
Is Arvaya Healthcare's ROC (Joel Greenblatt) % too high?
Arvaya Healthcare's current ROC (Joel Greenblatt) % is 10.84%. The Medical Distribution industry median ROC (Joel Greenblatt) % is 16.13. Arvaya Healthcare's value of 10.84% is 32.8% below this industry median. Based on the distribution chart, Arvaya Healthcare ranks #73 out of 119 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Arvaya Healthcare has a GF Score™ of 51/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Arvaya Healthcare's ROC (Joel Greenblatt) % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Arvaya Healthcare ranks #73 out of 119 companies for ROC (Joel Greenblatt) %. This places Arvaya Healthcare in the lower half of its industry. The industry median ROC (Joel Greenblatt) % is 16.13. Arvaya Healthcare's value of 10.84% is 32.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Distribution company?
The median ROC (Joel Greenblatt) % among Medical Distribution companies is 16.13, based on 119 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Arvaya Healthcare's current ROC (Joel Greenblatt) % of 10.84% is 32.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Arvaya Healthcare and its competitors. For the Medical Distribution industry, the median ROC (Joel Greenblatt) % is 16.13 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Arvaya Healthcare's current ROC (Joel Greenblatt) % is 10.84%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arvaya Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Arvaya Healthcare (BOM:524723) is currently considered Possible Value Trap. The stock's GF Value™ is ₹200.72, compared to a current price of ₹125.00 — trading 37.7% below its estimated fair value. The current ROC (Joel Greenblatt) % is 10.84% and 32.8% below the Medical Distribution industry median of 16.13. Arvaya Healthcare's overall GF Score™ is 51/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Arvaya Healthcare (BOM:524723), the current ROC (Joel Greenblatt) % is 10.84% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arvaya Healthcare (BOM:524723) Overvalued in 2026?
Based on GuruFocus' analysis, Arvaya Healthcare stock appears to be undervalued.
The current stock price of ₹125.00 is trading 37.7% below its estimated GF Value™ of ₹200.72.
GuruFocus considers Arvaya Healthcare to be Possible Value Trap.
Key valuation signals for BOM:524723:
ROC (Joel Greenblatt) %: 10.84%
GF Value™: ₹200.72 vs. price of ₹125.00 (37.7% below fair value)
Industry Position: 32.8% below the Medical Distribution median (#73 of 119)
No single metric tells the full story. See the BOM:524723 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arvaya Healthcare Ltd is focused on developing an integrated healthcare platform in India that combines hospital services, diagnostics, wellness services, and digital health management solutions. Its operations include multi-specialty hospitals, a digital health platform for appointment booking and health record management, diagnostic services including laboratory testing and home sample collection, and wellness facilities offering preventive and recovery-focused programs.
51GF Score
Get the complete analysis for BOM:524723
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:524723 has been successfully added to your 
